1、AI Innovations in HealthcareAhmed Serag,PhDProfessor&Director,AI Innovation LabWeill Cornell MedicineAround 20 years of experience developing and commercializing innovative AI solutions in medicine and healthcareAboutWeill Cornell Medicine in Qatar Value propositionLevel of diagnostic supportData Ac
2、quisitionData EnhancementData Interpretation Quantification of BiomarkersScreening and MonitoringDiagnosis and PredictionComputingPerceptionReasoningAI in Medicine&HealthcareNeonatal Brain developmentSerag et al.Fetal brain developmentSerag et al.Serag et al.Fetal brain developmentNeonatal brain dev
3、elopment2844 weeksSerag et al.BirthAdulthoodSerag et al.Multi-modal modeling of the human brain from birth to adulthoodBenjamens et al.AI in Pathologytissuestructuredetect tissue/artifactdetect tumordetect cellscelldecisionSerag et al.Deep Learning in Diagnostic PathologyAutomated identification of
4、tumour identification of tumour and calculated tumour percentage calculated tumour percentage in digital H&E tissue sections using image analysisTissueMark LungTissueMark BreastTissueMark ColonOriginal lungOriginal breastOriginal colonTissueMark ProstateOriginal prostate1 TissueMark is not intended
5、for diagnostic,monitoring or therapeutic purposes or in any other manner for regular medical practice.PathXL is the legal manufacturer and is a Philips companyCancer DetectionSerag et al.These slides detail early-stage internal research projects and intermediate output and do not make any claims per
6、taining to current Philips products.High resolution cellularity assessmentDeep learning to identify and segment cells at high resolution,classify them into tumour and non-tumour and count the relative numbers of cells to derive a quantitative percentage threshold of sample qualityy=1.1381xR=0.983605